RecruitingNot ApplicableNCT07246954
A Chaplain-clinician Led Spiritual Care (PEACE) Intervention on Spiritual/Religious Beliefs Related to Medical Care in Patients With Advanced Cancer: a Pilot Clinical Trial
Sponsor
M.D. Anderson Cancer Center
Enrollment
60 participants
Start Date
Dec 22, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
To examine the feasibility and acceptability of chaplain-clinician led spiritual care (PEACE: Perception, Exploring, Addressing, Compassionate Connection, Embracing) intervention in patients with advanced cancer.
Eligibility
Min Age: 18 Years
Inclusion Criteria7
- Eligibility Criteria
- Participants with advanced cancer (locally advanced, metastatic, recurrent, or incurable) seen by the participant supportive/palliative care mobile team at MD Anderson Cancer Center.
- Respond "somewhat to A great deal" to the question in the RBEC questionnaire "I will accept every possible medical treatment because my faith tells me to do everything I can to stay alive longer".
- Participant s aged 18 years or over.
- Karnofsky performance status ≥30% at time of inclusion into study.
- Normal cognitive status as determined by the supportive care clinicians based on the ability to understand the nature of the study and consent process.
- Only English-speaking, as determined by their ability to understand the informed consent, the intervention, and the assessment tools.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERPeace Intervention
Patients will participate in two PEACE intervention sessions, which will last 30-60 minutes each.
OTHERUsual Care
Usual care is a comprehensive evaluation of the physical, emotional, and spiritual needs of the patient by the Supportive/Palliative Care medical team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07246954
Related Trials
A Study of PHN-012 in Patients With Advanced Solid Tumors
NCT0712787413 locations
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
NCT0573508018 locations
SPECT Imaging for Pharmacokinetics and dosimEtry Towards TREATment Optimization
NCT063890971 location
Combination of Immune Checkpoint in Locally Advanced or Metastatic MSI/dMMR Esogastric Adenocarcinomas
NCT063461974 locations
Pilot Trial of Spiritual Care Interventions for Patients With Cancer
NCT068113762 locations